IL-1β-induced transcriptional up-regulation of bradykinin B 1 and B2 receptors in murine airways

American Journal of Respiratory Cell and Molecular Biology

Volumn 36, Issue 6, 2007, Pages 697-705

  Zhang, Yaping ^a   Adner, Mikael ^a   Cardell, Lars Olaf ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bradykinin; IL 1 ; JNK; Receptor; Remicade

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; ANTIBODY; BRADYKININ B1 RECEPTOR; BRADYKININ B2 RECEPTOR; BRADYKININ DERIVATIVE; BRADYKININ[1-8]; DACTINOMYCIN; INFLIXIMAB; INTERLEUKIN 1BETA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PEPTIDE DERIVATIVE; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; ANTIINFLAMMATORY AGENT; BRADYKININ; DRUG DERIVATIVE; ENZYME INHIBITOR; MONOCLONAL ANTIBODY; N(G) METHYLARGININE;

AIRWAY; ANIMAL TISSUE; ARTICLE; ASTHMA; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CHRONIC INFLAMMATION; CONTROLLED STUDY; CYTOKINE RELEASE; GENE EXPRESSION REGULATION; GENETIC STABILITY; IN VITRO STUDY; INFLAMMATION; MALE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; STIMULUS RESPONSE; TRANSCRIPTION REGULATION; ANIMAL; BAGG ALBINO MOUSE; GENETIC TRANSCRIPTION; GENETICS; HISTOLOGY; HUMAN; METABOLISM; MUSCLE CONTRACTION; PHYSIOLOGY; SMOOTH MUSCLE; TRACHEA;

MURINAE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; ASTHMA; BRADYKININ; BRONCHIAL HYPERREACTIVITY; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-1BETA; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MICE; MICE, INBRED BALB C; MUSCLE CONTRACTION; MUSCLE, SMOOTH; OMEGA-N-METHYLARGININE; RECEPTOR, BRADYKININ B1; RECEPTOR, BRADYKININ B2; SIGNAL TRANSDUCTION; TRACHEA; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34249900489     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2005-0369OC     Document Type: Article

References (37)

1. Grootendorst DC, Rabe KF. Mechanisms of bronchial hyperreactivity in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc 2004;1:77-87.
2. Molimard M, Naline E, Boichot E, Devillier P, Lagente V, Begaud B, Advenier C. In vitro-induced human airway hyperresponsiveness to bradykinin. Eur Respir J 1998;12:1301-1306.
3. Lappalainen U, Whitsett JA, Wert SE, Tichclaar JW, Bry K. Interleukin-1β causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung. Am J Respir Cell Mol Biol 2005;32:311-318.
4. Broide DH, Lotz M, Cuomo AJ, Coburn DA, Federman EC, Wasserman SI. Cytokines in symptomatic asthma airways. J Allergy Clin Immunol 1992;89:958-967.
5. Borish L, Mascali JJ, Dishuck J, Beam WR, Martin RJ, Rosenwasser LJ. Detection of alveolar macrophage-derived IL-1 beta in asthma. Inhibition with corticosteroids. J Immunol 1992;149:3078-3082.
6. Tsukagoshi H, Sakamoto T, Xu W, Barnes PJ, Chung KF. Effect of interleukin-1 beta on airway hyperresponsiveness and inflammation in sensitized and nonsensitized Brown-Norway rats. J Allergy Clin Immunol 1994;93:464-469.
7. Barnes PJ. Bradykinin and asthma. Thorax 1992;47:979-983.
8. Regoli D, Barabe J. Pharmacology of bradykinin and related kinins. Pharmacol Rev 1980;32:1-46.
9. Fuller RW, Dixon CM, Cuss FM, Barnes PJ. Bradykinin-induced bronchoconstriction in humans: mode of action. Am Rev Respir Dis 1987; 135:176-180.
10. Hall JM. Bradykinin receptors: pharmacological properties and biological roles. Pharmacol Ther 1992;56:131-190.
11. Marceau F, Hess JF, Bachvarov DR. The B1 receptors for kinins. Pharmacol Rev 1998;50:357-386.
12. Wadgaonkar R, Pierce JW, Somnay K, Damico RL, Crow MT, Collins T, Garcia JG. Regulation of c-Jun N-terminal kinase and p38 kinase pathways in endothelial cells. Am J Respir Cell Mol Biol 2004;31:423-431.
13. Wada T, Penninger JM. Mitogen-activated protein kinases in apoptosis regulation. Oncogene 2004;23:2838-2849.
14. Zhang Y, Adner M, Cardell LO. Up-regulation of bradykinin receptors in a murine in-vitro model of chronic airway inflammation. Eur J Pharmacol 2004;489:117-126.
15. 2A-mediated contraction. Br J Pharmacol 2002;137:971-982.
16. Bain J, McLauchlan H, Elliott M, Cohen P. The specilicities of protein kinase inhibitors: an update. Biochem J 2003;371:199-204.
17. Barr RK, Kendrick TS, Bogoyevitch MA. Identification of the critical features of a small peptide inhibitor of JNK activity. J Biol Chem 2002;277:10987-10997.
18. Katsumata N, Shimokawa H, Seto M, Kozai T, Yamawaki T, Kuwata K, Egashira K, Ikegaki I, Asano T, Sasaki Y, et al. Enhanced myosin light chain phosphorylations as a central mechanism for coronary artery spasm in a swine model with interleukin-1beta. Circulation 1997;96: 4357-4363.
19. Kandabashi T, Shimokawa H, Miyata K, Kunihiro I, Kawano Y, Fukata Y, Higo T, Egashira K, Takahashi S, Kaibuchi K, et al. Inhibition of myosin phosphatase by upregulated rho-kinase plays a key role for coronary artery spasm in a porcine model with interleukin-1beta. Circulation 2000;101:1319-1323.
20. Zhang Y, Adner M, Cardell LO. Interleukin-1beta attenuates endothelin B receptor-mediated airway contractions in a murine in vitro model of asthma: roles of endothelin converting enzyme and mitogen-activated protein kinase pathways. Clin Exp Allergy 2004;34:1480-1487.
21. Regoli D, Rizzi A, Perron SI, Gobeil F Jr. Classification of kinin receptors. Biol Chem 2001;382:31-35.
22. Marceau F. Kinin B1 receptors: a review. Immunopharmacology 1995;30: 1-26.
23. Knight DM, Trinh H, Le J, Siegel S, Shealy D, McDonough M, Scallon B, Moore MA, Vilcek J, Daddona P, et al. Construction and initial characterization of a mouse-human chimeric anti-TNF antibody. Mol Immunol 1993;30:1443-1453.
24. Scallon BJ, Moore MA, Trinh H, Knight DM, Ghrayeb J. Chimeric anti-TNF-alpha monoclonal antibody cA2 binds recombinant transmembrane TNF-alpha and activates immune effector functions. Cytokine 1995;7:251-259.
25. Elliott MJ, Maini RN, Feldmann M, Long-Fox A, Charles P, Katsikis P, Brennan FM, Walker J, Bijl H, Ghrayeb J, et al. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha. Arthritis Rheum 1993;36:1681-1690.
26. Nahar IK, Shojania K, Marra CA, Alamgir AH, Anis AH. Infliximab treatment of rheumatoid arthritis and Crohn's disease. Ann Pharmacother 2003;37:1256-1265.
27. Chung KF, Barnes PJ. Cytokines in asthma. Thorax 1999;54:825-857.
28. Huang TJ, Haddad EB, Fox AJ, Salmon M, Jones C, Burgess G, Chung KF. Contribution of bradykinin B(1) and B(2) receptors in allergen-induced bronchial hyperresponsiveness. Am J Respir Crit Care Med 1999;160:1717-1723.
29. Tsukagoshi H, Shimizu Y, Horie T, Fukabori Y, Iwamae S, Hisada T, Ishizuka, T, Iizuka K, Dobashi K, Mori M. Regulation by interleukin-1beta of gene expression of bradykinin B1 receptor in MH-S murine alveolar macrophage cell line. Biochem Biophys Res Commun 1999;259:476-482.
30. Watson ML, Smith D, Bourne AD, Thompson RC, Westwick J. Cytokines contribute to airway dysfunction in antigen-challenged guinea pigs: inhibition of airway hyperreactivity, pulmonary eosinophil accumulation, and tumor necrosis factor generation by pretreatment with an interleukin-1 receptor antagonist. Am J Respir Cell Mol Biol 1993;8:365-369.
31. Yoshimoto S, Ishizaki Y, Mori A, Sasaki T, Takakura K, Murota S. The role of cerebral microvessel endothelium in regulation of cerebral blood flow through production of endothelin-1. J Cardiovasc Pharmacol 1991;17:S260-S263.
32. Birrell MA, Hardaker E, Wong S, McCluskie K, Catley M, De Alba J, Newton R, Haj-Yahia S, Pun KT, Watts CJ, et al. 1kappa-B kinase-2 inhibitor blocks inflammation in human airway smooth muscle and a rat model of asthma. Am J Respir Crit Care Med 2005;172:962-971.
33. Gerthoffer WT, Singer CA. MAPK regulation of gene expression in airway smooth muscle. Respir Physiol Neurobiol 2003;137:237-250.
34. Lee SA, Fitzgerald SM, Huang SK, Li C, Chi DS, Milhorn DM, Krishnaswamy G. Molecular regulation of interleukin-13 and monocyte chemoattractant protein-1 expression in human mast cells by interleukin-1beta. Am J Respir Cell Mol Biol 2004;31:283-291.
35. Wuyts WA, Vanandenaerde BM, Dupont LJ, Demedts MG, Verleden GM. Involvement of p38 MAPK, JNK, p42/p44 ERK and NF-kappaB in IL-1beta-induced chemokine release in human airway smooth muscle cells. Respir Med 2003;97:811-817.
36. Yang CM, Chien CS, Wang CC, Hsu YM, Chiu CT, Lin CC, Luo SF, Hsiao LD. Interleukin-1beta enhances bradykinin-induced phosphoinositide hydrolysis and Ca2+ mobilization in canine tracheal smooth-muscle cells: involvement of the Ras/Raf/mitogen-activated protein kinase (MAPK) kinase (MEK)/MAPK pathway. Biochem J 2001;354: 439-446.
37. Zhang Y, Adner M, Cardell LO. Glucocorticoids suppress transcriptional up-regulation of bradykinin receptors in a murine in vitro model of chronic airway inflammation. Clin Exp Allergy 2005;35:531-538.